A major advance in cancer study is occurring with the use of mini-antibodies to reactivate damaged p53. This vital tumor inhibitor protein is frequently lost in many forms of cancer, leading uncontrolled tissue growth. https://mysocialname.com/story7047733/mini-antibodies-reactivate-tumor-suppressor-p53-new-potential-pathway-for-cancer-therapy